Funding & Partnerships MRA is a major funder with a track record of over $175 million invested in melanoma research and collaborations. Target partnerships with pharmaceutical companies, biotech firms, and philanthropy networks to co-fund research programs, patient registries, and translational studies that align with MRA's impact areas.

Technology & Data MRA maintains specialized research tools such as the Acral, Mucosal, and Uveal Melanoma Model Catalogs and operates a digital stack that includes analytics and outreach platforms. Propose services around data sharing platforms, biorepository tech integrations, and AI-driven grant analytics to optimize research funding and collaboration.

Executive & Leadership Recent leadership change with a new CEO and ongoing mission to expand impact presents an opening for strategic consulting, fundraising campaigns, and stakeholder engagement services to support governance, visibility, and donor stewardship.

Awareness & Engagement Strong donor-driven model with 100% of donations funding research and high Charity Navigator rating. Opportunities exist for sponsorships, cause campaigns, patient advocacy programs, and co-branded awareness initiatives that leverage MRA’s trusted brand.

Event & Thought Leadership Active participation in scientific retreats, conferences, and special sessions indicates potential for sponsored symposia, multi-institution collaboration platforms, and live event partnerships that amplify research outcomes and clinician engagement.